Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Spironolactone helps regrow hair in women with hair loss.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.